IV 
119TH CONGRESS 
1ST SESSION 
H. RES. 456 
Expressing support for the designation of the month of May 2025 as 
‘‘Progressive Supranuclear Palsy Awareness Month’’. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 29, 2025 
Mr. SUBRAMANYAM (for himself, Mr. AUCHINCLOSS, Mr. BACON, Mr. BEYER, 
Mr. BILIRAKIS, Ms. BROWNLEY, Mr. CLEAVER, Mr. COHEN, Ms. 
DELBENE, Mrs. FOUSHEE, Ms. MATSUI, Ms. MCCLELLAN, Mr. MCGOV-
ERN, Mr. QUIGLEY, Mr. POCAN, Mr. RYAN, Ms. SALINAS, Ms. SCANLON, 
Ms. SCHOLTEN, Mr. SCOTT of Virginia, Mr. AUSTIN SCOTT of Georgia, 
Ms. SHERRILL, Ms. STANSBURY, Mr. STANTON, Ms. GARCIA of Texas, 
Mr. THANEDAR, Mr. TONKO, Mrs. WATSON COLEMAN, Ms. KELLY of Illi-
nois, and Mr. VINDMAN) submitted the following resolution; which was 
referred to the Committee on Energy and Commerce 
RESOLUTION 
Expressing support for the designation of the month of May 
2025 as ‘‘Progressive Supranuclear Palsy Awareness Month’’. 
Whereas progressive supranuclear palsy, often referred to as 
‘‘PSP’’, is an adult onset neurodegenerative disorder that 
affects multiple areas of the brain and causes complex 
symptoms and care needs; 
Whereas, although some symptoms may appear similar to 
that of Parkinson’s disease, progressive supranuclear 
palsy is a distinct disease that is part of a family of con-
ditions clinically defined as atypical Parkinsonism; 
VerDate Sep 11 2014 
22:18 May 29, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR456.IH
HR456
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 456 IH 
Whereas, while estimates vary and the disorder is often 
misdiagnosed, approximately 30,000 Americans are living 
with progressive supranuclear palsy; 
Whereas the symptoms of progressive supranuclear palsy can 
include cognitive impairment, gait and balance difficul-
ties, speech and swallowing difficulties, stiffness, changes 
in personality, changes in vision, depression, and a vari-
ety of other symptoms that can have a severe impact on 
an individual’s quality of life and life expectancy; 
Whereas progressive supranuclear palsy is aggressive in its 
progression, with most patients becoming dependent on 
care in 3 to 4 years; 
Whereas there is currently no disease-modifying treatments 
and no known cure for progressive supranuclear palsy; 
Whereas progressive supranuclear palsy is believed to be 
caused by a combination of environmental factors and ge-
netics, but the exact cause is still unknown; 
Whereas there are thousands of family caregivers, friends, 
and loved ones whose lives are greatly affected by pro-
gressive supranuclear palsy; 
Whereas additional research, support services, and education 
are needed to maintain quality of life for those affected 
by the disease, reduce delays to diagnosis and access to 
proper care, lead to better treatments, and find a cure 
for progressive supranuclear palsy; and 
Whereas the establishment of the month of May 2025 as 
‘‘Progressive Supranuclear Palsy Awareness Month’’ will 
benefit patients, families, health care professionals, and 
communities across the country and further bolster 
awareness of the disorder: Now, therefore, be it 
Resolved, That the House of Representatives— 
VerDate Sep 11 2014 
22:18 May 29, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\HR456.IH
HR456
ssavage on LAPJG3WLY3PROD with BILLS
•HRES 456 IH 
(1) supports the designation of ‘‘Progressive 
Supranuclear Palsy Awareness Month’’; 
(2) supports the goals and ideals of ‘‘Progres-
sive Supranuclear Palsy Awareness Month’’; 
(3) supports research to find better treatments 
and a cure for progressive supranuclear palsy; and 
(4) commends the researchers, volunteers, orga-
nizations, families, and individuals across the coun-
try who are working to improve the lives of people 
living with progressive supranuclear palsy. 
Æ 
VerDate Sep 11 2014 
22:18 May 29, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\HR456.IH
HR456
ssavage on LAPJG3WLY3PROD with BILLS